Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 9 trials

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

5Total
Not Applicable (3)
P 4 (2)

Trial Status

Recruiting2
Enrolling By Invitation2
Not Yet Recruiting2
Unknown2
Withdrawn1

Clinical Trials (9)

Showing 9 of 9 trials
NCT07560852Not Yet Recruiting

Impact of Endotest on Patients' Quality of Life: a Cohort Study

NCT07532876Phase 4Enrolling By InvitationPrimary

Comparison of Elagolix and OCPs in Reducing Endometriosis Associated Pelvic Pain

NCT07393958Not ApplicableRecruitingPrimary

Impact of Food Supplementation on Quality of Life in Patients With Endometriosis and Pelvic Pain.

NCT07427849RecruitingPrimary

Observational Study on the Use of Ultrasound to Recognize Superficial Endometriosis in a Specific Area of the Pelvis (the Uterosacral Ligaments)

NCT05523284Enrolling By InvitationPrimary

Combining Ultrasound and Biomarkers to Diagnose Superficial Endometriosis

NCT06914752Not ApplicableWithdrawnPrimary

TENS for Endometriosis Pain in Adolescents and Young Adults

NCT07144904Phase 4Not Yet Recruiting

Assessing the Efficacy of Indocyanine Green for Ureter Identification During Robot-Assisted Surgery in Advanced-Stage Endometriosis

NCT03376451Not ApplicableUnknownPrimary

EndoSearch : Endometriosis Biomarkers

NCT04294017UnknownPrimary

CellAdhesionMolecule EndometriosisRatio - CAMERA

Showing all 9 trials

Research Network

Activity Timeline